Clinical Trial Update: Stratagen Quantitative Prostate MRI Platform Pilot Study [NA]

View source ↗

Summary

An ongoing clinical trial by Stratagen Bio evaluating a Quantitative Prostate MRI Platform for prostate cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Stratagen Bio, Inc. | Conditions: Prostate Cancer | NA | Status: RECRUITING